Results 1 to 10 of about 7,716 (188)
Akathisia with Erythromycin: Induced or precipitated? [PDF]
Saudi Pharmaceutical Journal, 2015 Objective: A 28-year-old male diagnosed with schizophrenia, maintaining well on Olanzapine, developed akathisia soon after addition of Erythromycin for Pityriasis Rosea. This prompted us to evaluate the relationship of Erythromycin and akathisia. Method:
Ankur Sachdeva, Ruchika Rathee
exaly +3 more sources
Akathisia Induced by Metoclopramide in a Pregnant Woman With Nausea and Vomiting: A Case Report [PDF]
Neuropsychopharmacology ReportsBackground Nausea and vomiting are common during pregnancy and can significantly impair maternal well‐being. Metoclopramide is widely used to treat these symptoms but may cause extrapyramidal side effects, including akathisia.
Ryohei Nakamura +6 more
doaj +2 more sources
Acetaminophen improves tardive akathisia induced by dopamine D2 receptor antagonists [PDF]
Journal of Pharmacological Sciences, 2023 Tardive akathisia is a movement disorder characterized by internal restlessness with an uncontrollable urge to move, leading to repetitive movements. It is a common side effect of long-term treatment with dopamine D2 receptor antagonists.
Koki Nagaoka +3 more
doaj +2 more sources
Tacrolimus-induced Akathisia in a Post-cardiac Transplant Patient: A Case Report [PDF]
Oman Medical JournalAkathisia, a prevalent drug-induced movement disorder, is characterized by inner restlessness and an irresistible urge to move. It can occur after starting a new medication, increasing the dose, or switching to another medication.
Thamer S. Alhowaish +4 more
doaj +2 more sources
Akathisia induced by concurrent use of mirogabalin and sulfamethoxazole-trimethoprim: a case report [PDF]
Journal of Pharmaceutical Health Care and SciencesBackground Mirogabalin and trimethoprim-sulfamethoxazole (TMP/SMX) are frequently used as supportive purpose during and/or after chemotherapy. Mirogabalin is used to treat neuropathic pain, whereas TMP/SMX is used to prevent pneumocystis pneumonia (PCP ...
Takashi Nakashima +6 more
doaj +2 more sources
Akathisia rate among psychiatric patients treated with Clozapine compared to Risperidone.
European Psychiatry, 2023 Introduction Patients’ cooperation, especially in medication taking, constitutes a significant challenge in psychiatric care. Psychiatric patients are often reluctant to take a specific pharmacological treatment because of side effects.
R. Stryjer, A. Shelef
doaj +1 more source
Frontiers in Psychiatry, 2021 Akathisia, which characterized by subjective restlessness and objective hyperactivity, is induced mostly by antipsychotics and antidepressants. Chronic akathisia is defined as persistence of symptoms for more than 3 months. The pathophysiology of chronic
Akihito Suzuki +5 more
doaj +1 more source
How to manage antipsychotic-induced akathisia
European Psychiatry, 2021 Introduction Akathisia is a relatively common adverse effect of antipsychotics although some second-generation antipsychotics are known to have a lower liability for the condition. The core feature of akathisia is mental unease characterized by a sense
N. Moura +4 more
doaj +1 more source
Escitalopram-induced akathisia in a patient with major depressive disorder: A rare case report
SAGE Open Medical Case Reports, 2022 Medication-induced akathisia is restlessness with excessive movements developing after initiation/ increasing or decreasing the dose of drugs. Herein, we reported the case of a 38-year-old widowed mother of two children, a known case of major depressive ...
Hareem Arshad +4 more
doaj +1 more source
A rare case with suicide due to akathisia after use of single dose venlafaxine [PDF]
Klinik Psikiyatri Dergisi, 2018 Akathisia is a movement disorder characterized by an inner sense of unease, unrest and dysphoria.Suicidal behavior related with akathisia in patients is one of serious harmful behaviors and requires rapid intervention.There is limited number of cases ...
Nermin Gündüz +3 more
doaj +1 more source